COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
{{output}}
The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the causative factor behind the 2019 global coronavirus pandemic (COVID-19). The main protease, known as Mpro, is encoded by the viral genome and is essential for viral replication. It has als... ...
